|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:XYZ_Biotech
|
|
gptkbp:awards
|
Best Workplace 2022
|
|
gptkbp:budget
|
2022
|
|
gptkbp:CEO
|
gptkb:John_Doe
|
|
gptkbp:clinicalTrials
|
gptkb:Asia
gptkb:Latin_America
gptkb:USA
Europe
Phase 1
Phase 2
Phase 3
Phase 3 Trials
Phase 4
|
|
gptkbp:communityEngagement
|
Health Fairs
Educational_Workshops
Scholarship_Programs
Volunteer_Programs
|
|
gptkbp:contact
|
+1-800-555-0199
|
|
gptkbp:employees
|
500
Paid Time Off
Retirement Plans
Health_Insurance
Employee_Stock_Options
|
|
gptkbp:founded
|
1990
|
|
gptkbp:founder
|
gptkb:Alice_Brown
|
|
gptkbp:hasCompetitors
|
gptkb:DEF_Pharmaceuticals
gptkb:JKL_Therapeutics
GHI Biopharma
MNO Health
|
|
gptkbp:headCoach
|
gptkb:Dr._Jane_Smith
|
|
gptkbp:headquarters
|
gptkb:Manhattan
gptkb:New_York,_USA
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
ABC Pharmaceuticals
|
|
gptkbp:investmentFocus
|
$100 million in R&D
[email protected]
|
|
gptkbp:market
|
$5 billion
Global
|
|
gptkbp:partnerships
|
gptkb:HealthCorp
|
|
gptkbp:patentCitation
|
200
|
|
gptkbp:products
|
Over-the-Counter Medications
Prescription Drugs
|
|
gptkbp:research_areas
|
Diabetes
Neurology
Infectious Diseases
Autoimmune Disorders
|
|
gptkbp:researchFocus
|
Oncology
Cardiovascular Diseases
|
|
gptkbp:revenue
|
$1 billion
|
|
gptkbp:socialResponsibility
|
Environmental Sustainability Programs
Community_Health_Initiatives
|
|
gptkbp:stockSymbol
|
ABCP
|
|
gptkbp:subsidiary
|
gptkb:ABC_Generics
gptkb:ABC_Research_Labs
|
|
gptkbp:sustainability
|
Carbon Neutral by 2030
Water Conservation Initiatives
Zero Waste by 2025
|
|
gptkbp:website
|
www.abcpharma.com
|